Skip to main content
. 2020 Dec 23;1(1):331–338. doi: 10.1089/pmr.2020.0115

Table 2.

Clinical Scenarios Based on Centers for Disease Control and Prevention Guidelines to Explore Knowledge

Clinical scenarios Agree n = 321 (%) Disagree n = 321 (%) Unsure n = 321 (%)
Serologic (blood) testing should be used to establish the presence or absence of SARS-CoV-2 infection or reinfection? 172 (53.58) 45 (14.02)a 104 (32.40)
Recovered patients can continue to have SARS-CoV-2 RNA detected in their upper respiratory specimens for up to 12 weeks 171 (53.27)a 8 (2.50) 142 (44.23)
Do you consider a patient to be contagious until a follow-up negative COVID-19 PCR test (not a rapid test)? 181 (56.39) 65 (20.25)a 75 (23.36)
For persons previously diagnosed with symptomatic COVID-19 who remain asymptomatic after recovery, retesting is recommended within three months after the date of symptom onset for the initial COVID-19 infection to ensure cure. 153 (47.66) 62 (19.32)a 106 (33.02)
I only trust results from COVID-19 PCR test,“not rapid” test. 69 (21.49) 109 (33.96)a 143 (44.55)
Two negative COVID-19 PCR tests should be standard to discontinue isolation and contact precautions. 172 (53.58) 76 (23.68)a 73 (22.74)
For most persons with COVID-19 illness, isolation and precautions can generally be discontinued 10 days after symptom onset and resolution of fever for at least 24 hours, without the use of fever-reducing medications and with improvement of other symptoms. 117 (36.45)a 91 (28.35) 113 (35.20)
When a patient who initially tested positive for COVID-19 is retested with a “rapid” test and is found to be negative, “I trust the negative result and isolation and contact precautions should be stopped” 41 (12.77) 154 (47.98)a 126 (39.25)
a

Correct answers based on CDC guidelines at the time of survey.

CDC, Centers for Disease Control and Prevention.